EASTHAM KARIN

VCYT

EASTHAM KARIN serves as Director at Veracyte, Inc. (VCYT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$1.50M

Net Position

Net Seller

$1.50M

Companies Traded

VCYT, NKTR

Active Period

Sep 2022 – Dec 2025

4 total trades

Most Recent

Sell VCYT

Dec 5, 2025 · $908.9K

EASTHAM KARIN's Insider Trading at Veracyte, Inc. (VCYT)

Buys

0 · $0.00

Sells

3 · $1.42M

Total Shares Bought

Total Shares Sold

34,264

VCYT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Dec 5, 2025↗	Sell	20,000	$45.45	$908.9K
Nov 5, 2025↗	Sell	9,674	$40.02	$387.2K
Jun 13, 2025↗	Sell	4,590	$26.66	$122.4K

EASTHAM KARIN's Insider Trading at Nektar Therapeutics (NKTR)

Buys

0 · $0.00

Sells

1 · $76.8K

Total Shares Bought

Total Shares Sold

21,267

NKTR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 14, 2022↗	Sell	21,267	$3.61	$76.8K	13,033

Related Insiders

John Leite

officer: Chief Commercial Officer-CLIA

VCYTSell · Mar 4, 2026

Rebecca Chambers

officer: Chief Financial Officer

VCYTSell · Mar 4, 2026

Marc Stapley

director, officer: Chief Executive Officer

VCYTSell · Mar 4, 2026

Annie McGuire

officer: SVP, General Counsel

VCYTSell · Mar 4, 2026

Phillip G. Febbo

officer: Chief Scientific & Med Officer

VCYTSell · Mar 2, 2026

ROBIN HOWARD W

director, officer: President & CEO

NKTRSell · Feb 18, 2026

ROBIN HOWARD W

President & CEO

NKTRSell · Feb 18, 2026

Jonathan Zalevsky

Chief R&D Officer

NKTRSell · Feb 18, 2026

Explore More Insider Trading Data

VCYT Insider Trading Activity

View all insider trades at Veracyte, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity